Recurrent Head and Neck Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00515Cisplatin1Recruiting1
DB00530Erlotinib1Active Not Recruiting1
DB09037Pembrolizumab1Active Not Recruiting1
DB06176Romidepsin1Recruiting1
DB12218AZD-53632Recruiting1
DB08916Afatinib2Recruiting1
DB11967Binimetinib2Recruiting1
DB00958Carboplatin2Recruiting1
DB00002Cetuximab2Completed1
DB00002Cetuximab2Recruiting1
DB00515Cisplatin2Recruiting1
DB12483Copanlisib2Recruiting1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB12282Defactinib2Recruiting1
DB12147Erdafitinib2Recruiting1
DB00544Fluorouracil2Recruiting1
DB11795GSK-26367712Recruiting1
DB11886Infigratinib2Recruiting1
DB14723Larotrectinib2Recruiting1
DB11740MK-17752Recruiting1
DB09035Nivolumab2Recruiting2
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting1
DB09037Pembrolizumab2Recruiting2
DB06366Pertuzumab2Recruiting1
DB00707Porfimer sodium2Recruiting1
DB11836Sapanisertib2Recruiting1
DB01268Sunitinib2Recruiting1
DB12108Taselisib2Recruiting1
DB12200Tivantinib2Completed1
DB08911Trametinib2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB08828Vismodegib2Recruiting1